Expert Due Diligence & Regulatory Compliance Services for Bio-Med Companies

Professional Due Diligence and Regulatory Compliance for the Israeli Bio Med Sector

The Bottom Line for Bio Med Founders and Investors
In Israel’s thriving Bio-Med sector professional due diligence is the ultimate strategic tool for securing international investment and clinical success. For pioneering cell therapy companies or innovative medical device manufacturers regulatory failure is the most common deal breaker during M&A or funding rounds. Implementing a 360 degree due diligence process validates your technology and maximizes company value by ensuring you meet the stringent expectations of the FDA EMA and international partners.

In today’s dynamic healthcare landscape particularly in Israel’s thriving Bio-Med sector professional due diligence and regulatory compliance are fundamental to sustainable growth and international success. Whether you are a pioneering cell therapy company an innovative medical device manufacturer or a cutting-edge E-Health venture our comprehensive due diligence services ensure your company meets both regulatory requirements and business objectives.

Why Professional Due Diligence is Critical in Bio Med

The Israeli Bio-Med sector continues to attract significant international attention and investment. However with this opportunity comes increased scrutiny from regulators investors and potential partners.

Professional due diligence is not merely a compliance exercise but a strategic tool for validating your technology and processes, enhancing investor confidence, preparing for international expansion, optimizing operational efficiency, ensuring regulatory compliance, protecting intellectual property, and maximizing company value.

Our Comprehensive Due Diligence Process

Our due diligence process includes the following detailed assessments to ensure a full 360 degree view of your organization.

Clinical Development Assessment

Clinical trial design and protocols
Patient enrollment and timeline analysis
Safety data evaluation
CRO relationship assessment
Regulatory correspondence review
Clinical site compliance verification
Data management systems audit

Manufacturing and Quality Systems

GMP compliance verification
Manufacturing process validation
Quality control systems assessment
Raw material sourcing evaluation
Supply chain resilience analysis
Facility inspection and audit
Environmental monitoring review

Regulatory Compliance Verification

FDA/EMA/AMAR requirements assessment
Registration status review
Regulatory strategy evaluation
Submission documentation audit
Quality system compliance
Risk management system assessment
Change control procedures review

Intellectual Property Analysis

Patent portfolio review
Freedom to operate assessment
IP protection strategy evaluation
Licensing agreements audit
Trade secret protection assessment
Technology transfer agreements
IP litigation history review

E-Health Specific Evaluation

Data protection compliance including ISO 27001, GDPR, and HIPAA
Cybersecurity measures assessment
Software validation and verification
Electronic systems audit
Digital health regulations compliance
Remote healthcare delivery systems
Data integrity verification

Business Operations Assessment

Market analysis and positioning
Commercial strategy evaluation
Financial planning and projections
Resource allocation efficiency
Operational risk assessment
Partnership and collaboration review
Growth strategy validation

Specialized Focus Areas in Due Diligence

Segment	R&D and Validation Focus	Compliance Goals
Bio-Pharma	Manufacturing process validation and storage procedures.	Process scalability and release criteria verification.
Medical Device	Design control documentation and V&V data.	Technical file completeness and post-market surveillance.
E-Health	Software development lifecycle and system architecture.	Data security protocols and regulatory classification.

Process Implementation and Value Proposition

Our systematic approach includes an initial assessment for document review and process analysis. This is followed by a detailed analysis for gap identification and risk mitigation planning. We then provide implementation support for corrective action guidance and system enhancement. Finally we conduct follow-up and maintenance for progress monitoring and effectiveness verification. This local expertise combined with global standards allows Israeli companies to achieve accelerated regulatory approval and increased company value.

Frequently Asked Questions

How does local Israeli expertise benefit an international investor?
We understand the unique culture and pace of the Israeli Start-Up Nation while applying the rigid auditing standards required by the FDA and EMA to ensure the investment is safe.

What is included in a Clinical Development Assessment?
We audit the relationship with the CRO and verify that the clinical data management systems meet regulatory integrity requirements to prevent future submission rejections.

Can you help prepare a company for an exit or M&A?
Yes. Our exit readiness assessment identifies regulatory gaps that could lower the company valuation during the buyer’s due diligence allowing you to fix them in advance.